๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Myelofibrosis with massive hepatosplenomegaly and osteolytic bone lesions

โœ Scribed by Ginger M. Merry; Paul B. Aronowitz


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
126 KB
Volume
5
Category
Article
ISSN
1553-5592

No coin nor oath required. For personal study only.

โœฆ Synopsis


An 83-year-old man with a 7-year history of myelofibrosis presented to the hospital with progressive weakness and fatigue, which resulted in him tripping and falling onto his left hand and arm 1 day prior to admission. His past medical history was significant for transfusion-dependent anemia and hypertension. His current treatment regimen for myelofibrosis included thalidomide and darbopoetin alfa.

Physical examination revealed a pale and edematous man who was holding his injured arm to his chest, but in no distress. He had massive hepatosplenomegaly (Figure 1


๐Ÿ“œ SIMILAR VOLUMES


Osteolytic Lesions in the Craniofacial S
โœ Richard J. Wright; Bryan T. Ambro ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 449 KB

Case report: A 52 year old African American woman with a history of pulmonary sarcoidosis and non-compliance with her medical management presents to the otolaryngology clinic complaining of nasal obstruction, crusting, and epistaxis. On exam she had significant nasal crusting, friable mucosa with a

Zoledronic acid is superior to pamidrona
โœ Lee S. Rosen; David H. Gordon; William Dugan Jr.; Pierre Major; Peter D. Eisenbe ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 131 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND Treatment with zoledronic acid (Zol) was compared with a dose of 90 mg of pamidronate (Pam) in breast carcinoma (BC) patients with at least 1 osteolytic lesion based on data from a Phase III, randomized trial. ## METHODS Overall, 1130 patients with breast carcinoma who